Strategies to Prevent Transcatheter Heart Valve Dysfunction in Low Risk Transcatheter Aortic Valve Replacement

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 124 participants.

Also called NCT03557242

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 124 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03557242
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT03557242. Randomized; no masking; primary purpose treatment. Start 2018-07-05 (actual); primary completion 2023-07-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Strategies to Prevent Transcatheter Heart Valve Dysfunction in Low Risk Transcatheter Aortic Valve Replacement
Condition
Aortic Stenosis
Intervention (Other)
Warfarin plus Aspirin
Intervention (Other)
Aspirin Only
Lead sponsor
Medstar Health Research Institute (class: other)

Record details

Record id
cardio:ct-nct03557242
Content hash
33d128c8468f8f656580f81cdeca6def27acac902e2a4c53a6666b2fa7398f19